Psychology › Section D · States of consciousness › Topic D.5
Substance use and psychoactive drugs
From a morning coffee to a hospital painkiller, psychoactive drugs change consciousness by working on the brain's own chemical messengers. This topic explains how clinicians define a substance use disorder, how each major class of drug acts, and what the current evidence says. It is education, not a tool for diagnosing anyone.
Substance use disorder in DSM-5-TR
A psychoactive drug is any substance that alters mood, perception or consciousness by acting on the brain. The current clinical manual, DSM-5-TR (American Psychiatric Association, 2022), describes a substance use disorder as a problematic pattern of use that causes significant distress or impairment. Its 11 criteria fall into four groups: impaired control (using more than intended, failed attempts to cut down, craving), social impairment, risky use despite known harm, and pharmacological signs (tolerance and withdrawal). Severity is rated mild, moderate or severe by how many criteria occur within 12 months. Only a qualified clinician can make this diagnosis.
Tolerance, withdrawal and dependence
Tolerance means needing more of a drug for the effect a smaller amount once gave, which can push intake to dangerous levels. Withdrawal is the unpleasant set of symptoms when regular use stops, usually opposite to the drug's effect: stopping a sedative brings agitation. Together these signal physical dependence, a change in the body's normal functioning. Psychological dependence is an emotional need for the drug, felt as craving, which DSM-5 added as a criterion in 2013. Physical dependence alone is not a disorder: a patient taking a prescribed painkiller as directed may show both signs, and DSM-5-TR does not count them then.
One map: agonists and antagonists
Every psychoactive drug works by changing the brain's own neurotransmitter systems. As the neurons topic showed, an agonist increases a system's activity, by mimicking the transmitter or keeping it in the synapse longer, while an antagonist reduces it, often by blocking receptors. So each class can be learned by its target and direction. Depressants boost GABA, the main inhibitory transmitter. Most stimulants boost dopamine, which is tied to reward and craving, so they carry a high risk of compulsive use. Opioids imitate the body's natural painkillers. Hallucinogens act mainly on serotonin or glutamate receptors.
Depressants: alcohol and sedatives
A depressant suppresses central nervous system activity. Alcohol, barbiturates and benzodiazepines all enhance GABA: they bind to the GABA receptor's chloride channel, letting negative ions into the neuron so it is less likely to fire. Hence some are prescribed for anxiety or sleep problems. Low doses of alcohol can feel euphoric; higher doses sedate. Alcohol slows reaction time, blurs vision and weakens self-control, and heavy drinking can cause blackouts. Drinking in pregnancy can cause fetal alcohol spectrum disorders, the most severe being fetal alcohol syndrome. After long, heavy use, withdrawal from any of the three can bring seizures and be life-threatening, so stopping needs medical supervision.
Stimulants and dopamine
Stimulants raise overall neural activity, and most are dopamine agonists. Cocaine blocks dopamine reuptake, so the transmitter lingers in the synapse; amphetamines block reuptake and also push extra dopamine out of the terminal. Smoked or injected forms reach the brain fastest, giving an intense, brief high that invites repeated use. Methamphetamine is a potent amphetamine with serious long-term harms, including paranoia. MDMA (ecstasy) mainly releases serotonin, bringing energy and emotional warmth. Some amphetamine-based medicines are prescribed for ADHD, raising activity in impulse-control regions such as the prefrontal cortex. Heavy repeated use can deplete dopamine, noradrenaline and serotonin, leaving low mood that drives further use.
Caffeine and nicotine
Caffeine is the world's most widely used psychoactive drug, though far milder than other stimulants. It is an adenosine antagonist: adenosine builds up during waking and promotes sleepiness, so blocking it keeps you alert. Very high intake can cause insomnia, agitation and an irregular heartbeat. DSM-5-TR recognises caffeine intoxication and caffeine withdrawal, but lists caffeine use disorder only as a condition for further study. Nicotine acts on acetylcholine receptors that feed reward circuits, and is highly addictive. Vaping is not harmless: most e-cigarettes deliver nicotine, and a 2019 US outbreak of severe lung injury was linked mainly to vitamin E acetate in illicit THC vaping products.
Opioids
Opioids such as morphine, codeine, heroin, oxycodone and fentanyl imitate the body's own opioids, such as the endorphins, which bind opioid receptors to dull pain and produce pleasure. Opiates are the natural compounds from the opium poppy; opioid also covers synthetic drugs. The main danger is respiratory depression: too high a dose stops breathing. Withdrawal feels like a severe flu and is seldom life-threatening in itself, but tolerance fades during abstinence, so returning to an old dose can kill. The US overdose crisis came in waves: prescription opioids from the late 1990s, heroin from about 2010, then illicit fentanyl from about 2013. Methadone and buprenorphine are long-term treatments that reduce deaths, and naloxone, an opioid antagonist, can reverse an overdose.
Hallucinogens and cannabis
Hallucinogens profoundly alter perception, time and body image. LSD, mescaline and psilocybin are serotonin agonists; PCP and ketamine are antagonists at the NMDA glutamate receptor. Ketamine is an anaesthetic in human as well as veterinary medicine, and a related drug, esketamine, was approved in the US in 2019 for depression that has not responded to other treatment. As a group, hallucinogens are less likely than other classes to produce compulsive use. Cannabis, often given its own category, acts on cannabinoid receptors; its evidence is weighed in the second worked example below.
Worked example: predicting withdrawal from the mechanism
A long-term benzodiazepine user and a heavy coffee drinker both stop abruptly. Predict what each will feel. 1. Name each action: the benzodiazepine strengthens GABA, the brain's brake; caffeine blocks adenosine, a sleep-promoting signal. 2. Apply the rule that withdrawal opposes the drug: with the brake suddenly weaker, the first person may face anxiety, insomnia and, after long heavy use, seizures; with adenosine unblocked, the coffee drinker is likely to feel drowsy and sluggish, often with a headache. 3. Weigh the risk: sedative withdrawal can be dangerous and needs medical care, while caffeine withdrawal is unpleasant but passes within days. 4. Check: both predictions follow from the map.
Worked example: weighing a cannabis headline
A headline announces that science has proved cannabis is medicine. Test it. 1. Look for the strongest summary of evidence, not a single study: in 2017 the US National Academies of Sciences, Engineering, and Medicine graded many health claims. 2. Read what had substantial evidence: chronic pain in adults, chemotherapy-induced nausea and patient-reported multiple sclerosis spasticity, with limited or insufficient evidence for many other claimed uses. 3. Read the risks: substantial evidence linking use to psychosis, especially with frequent use, and to traffic crashes. 4. Rewrite the claim: cannabis-based products help a few specific conditions, other uses remain unproven, and use carries real risks. 5. Check: this is narrower than both the headline and a blanket dismissal.
Common mistakes to avoid
First, equating physical dependence with a disorder: it also occurs with medicines used as prescribed. Second, believing alcohol sharpens reactions: it slows them. Third, calling alcohol a stimulant because the first drink feels lively: it is a depressant. Fourth, treating caffeine use disorder as an established diagnosis: only caffeine intoxication and withdrawal are. Fifth, thinking opioid withdrawal is the main danger: overdose is, especially once tolerance has faded. Sixth, using this vocabulary as a self-test: worries about anyone's use belong with a doctor or counsellor, or the free US SAMHSA helpline, 1-800-662-4357.
Key takeaways
DSM-5-TR defines a substance use disorder by 11 criteria in four groups, rated mild, moderate or severe over 12 months; only clinicians diagnose. Tolerance and withdrawal mark physical dependence, craving marks psychological dependence, and physical dependence alone is not a disorder. Depressants boost GABA, most stimulants boost dopamine, caffeine blocks adenosine, nicotine acts on acetylcholine receptors, opioids imitate endorphins, and hallucinogens act on serotonin or NMDA receptors. Alcohol slows reaction time. Opioid overdose stops breathing; naloxone reverses it. The 2017 National Academies review backed a few medical uses of cannabis and some of its risks.
Flashcards
Flashcard
A problematic pattern of use causing significant distress or impairment
Test your understanding
Question 1 of 5
Under DSM-5-TR, which statement about tolerance and withdrawal is accurate?
Question 2 of 5
Cocaine and amphetamines both raise dopamine activity mainly by:
Question 3 of 5
Which pair of effects does a moderate to high dose of alcohol typically produce?
Question 4 of 5
How does caffeine keep a person alert?
Question 5 of 5
The 2017 National Academies review found substantial evidence that cannabis or cannabinoids are effective for:
